 systemic review evaluating VD following sclerotherapy of varicose veins, reticular
veins and telangiectasias. While the prevalence of VD was
difﬁcult to determine, two RCTs reported no VDs (95 and
75 patients treated, respectively). In large case series
(>500 patients), the prevalence of VD ranged from
0.09% to 2%. In a meta-analysis that included over 90